Demonstrações financeiras detalhadas de REGENXBIO Inc. (RGNX): demonstração de resultados, balanço patrimonial e fluxo de caixa. Acompanhe a evolução de margens, dívida, liquidez e rentabilidade ano a ano com até 20 anos de histórico.
Resumo da Análise
REGENXBIO Inc. registou receitas de $170.4M no último exercício, com um CAGR de 5 anos de 2.0%.
Margens dos últimos 12 meses: margem bruta 54.2%, margem operacional -94.1%, margem líquida -112.6%.
Ao preço atual de $7.98, RGNX apresenta lucros negativos (P/L não significativo) e um ROE de -220.07%. A capitalização de mercado é de $413M.
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Receita | $4.6M | $10.4M | $218.5M | $35.2M | $154.6M | $470.3M | $112.7M | $90.2M | $83.3M | $170.4M |
| Custo da Receita | $959000 | $1.7M | $9.6M | $8.2M | $35.7M | $51.8M | $54.5M | $37.2M | $33.6M | $20.3M |
| Lucro Bruto | $3.6M | $8.7M | $208.9M | $27.0M | $118.9M | $418.5M | $58.2M | $53.0M | $49.8M | $150.1M |
| P&D | $45.5M | $57.2M | $83.9M | $124.2M | $166.3M | $181.4M | $242.5M | $232.3M | $208.5M | $228.3M |
| Despesas Gerais e Administrativas | $23.6M | $27.2M | $36.9M | $51.8M | $63.8M | $79.3M | $85.3M | $88.5M | $76.6M | $82.9M |
| Despesas Operacionais | $69.0M | $84.6M | $120.8M | $176.0M | $238.1M | $258.5M | $321.1M | $321.2M | $283.1M | $311.3M |
| Lucro Operacional | -$65.3M | -$75.9M | $88.1M | -$149.0M | -$119.2M | $160.0M | -$262.9M | -$268.1M | -$233.3M | -$161.2M |
| EBITDA | -$64.8M | -$73.2M | $92.1M | -$90.3M | -$96.8M | $177.1M | -$244.2M | -$239.5M | -$198.2M | -$133.3M |
| Despesas com Juros | 0 | 0 | 0 | 0 | $771000 | $26.3M | $23.3M | $6.9M | $12.7M | $45.0M |
| Lucro Antes de Impostos | -$63.4M | -$73.2M | $104.1M | -$97.5M | -$106.0M | $141.2M | -$280.4M | -$263.6M | -$227.1M | -$193.9M |
| Imposto | -$435000 | $686000 | $4.2M | -$2.8M | $5.2M | $13.4M | -$84000 | -$152000 | 0 | 0 |
| Lucro Líquido | -$63.0M | -$73.2M | $99.9M | -$94.7M | -$111.2M | $127.8M | -$280.3M | -$263.5M | -$227.1M | -$193.9M |
| LPA | $-2.38 | $-2.45 | $2.73 | $-2.58 | $-2.98 | $3.01 | $-6.50 | $-6.02 | $-4.59 | $-3.76 |
| LPA Diluído | $-2.38 | $-2.45 | $2.73 | $-2.58 | $-2.98 | $2.91 | $-6.50 | $-6.02 | $-4.59 | $-3.76 |
| Ações em Circulação (Diluídas) | $26.4M | $29.9M | $36.6M | $36.7M | $37.3M | $43.9M | $43.2M | $43.7M | $49.5M | $51.6M |
Demonstração de Resultados (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Receita | $29.7M | $30.3M | $6.4M | $108.0M |
| Lucro Bruto | -$32.1M | $24.4M | -$4.7M | $107.0M |
| Lucro Operacional | -$52.4M | -$57.6M | -$83.4M | $29.3M |
| EBITDA | -$44.9M | -$51.0M | -$77.5M | $34.3M |
| Lucro Líquido | -$61.9M | -$67.1M | -$90.1M | $22.7M |
| LPA | $-1.20 | $-1.30 | $-1.72 | $0.43 |
| LPA Diluído | $-1.20 | $-1.30 | $-1.72 | $0.43 |
Balanço (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caixa e Equivalentes | $24.8M | $46.7M | $75.6M | $69.5M | $338.4M | $345.2M | $97.0M | $34.5M | $57.5M | $34.5M |
| Investimentos de Curto Prazo | $64.7M | $114.1M | $244.2M | $226.7M | $137.3M | $112.2M | $267.7M | $240.7M | $177.2M | $195.6M |
| Contas a Receber | $1.0M | $473000 | $8.6M | $38.1M | $43.0M | $32.4M | $30.3M | $26.3M | $21.6M | $27.4M |
| Estoque | $1.8M | $5.3M | $5.7M | 0 | $10.5M | 0 | 0 | 0 | 0 | 0 |
| Ativos Circulantes | $93.4M | $168.0M | $337.9M | $345.0M | $531.2M | $518.8M | $416.0M | $335.0M | $278.0M | $281.3M |
| Imobilizado | $9.3M | $14.0M | $28.7M | $39.1M | $120.3M | $192.5M | $206.8M | $192.6M | $171.3M | $152.0M |
| Ágio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Intangíveis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Totais | $172.7M | $198.7M | $543.8M | $497.9M | $708.2M | $1.11B | $833.3M | $574.0M | $466.0M | $453.0M |
| Contas a Pagar | $1.5M | $4.8M | $4.4M | $6.4M | $10.6M | $11.4M | $27.2M | $22.8M | $22.8M | $21.4M |
| Dívida de Curto Prazo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $47.9M |
| Passivos Circulantes | $9.7M | $14.4M | $22.2M | $33.7M | $81.4M | $130.5M | $130.4M | $130.3M | $103.2M | $118.1M |
| Dívida de Longo Prazo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $147.4M |
| Passivos Totais | $11.0M | $15.6M | $35.0M | $47.7M | $330.4M | $349.6M | $317.1M | $262.2M | $206.3M | $350.3M |
| Reservas | -$114.6M | -$187.8M | -$83.0M | -$177.8M | -$289.1M | -$161.2M | -$441.6M | -$705.0M | -$932.1M | -$1.13B |
| Patrimônio Líquido | $161.7M | $183.0M | $508.8M | $450.2M | $377.8M | $764.3M | $516.2M | $311.7M | $259.7M | $102.7M |
| Dívida Total | 0 | 0 | $5.9M | $11.3M | $72.7M | $86.7M | $94.8M | $89.3M | $82.0M | $260.5M |
| Dívida Líquida | -$89.6M | -$160.8M | -$313.9M | -$284.9M | -$403.1M | -$370.8M | -$269.8M | -$186.0M | -$152.7M | $30.4M |
| Capital de Giro | $83.7M | $153.6M | $315.7M | $311.4M | $449.8M | $388.4M | $285.5M | $204.7M | $174.8M | $163.2M |
Balanço (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caixa e Equivalentes | $58.8M | $34.5M | $15.2M | $36.5M |
| Ativos Totais | $525.2M | $453.0M | $341.9M | $386.6M |
| Passivos Totais | $363.8M | $350.3M | $320.8M | $314.9M |
| Patrimônio Líquido | $161.5M | $102.7M | $21.1M | $71.8M |
| Dívida Total | $268.1M | $260.5M | $71.1M | $69.0M |
Fluxo de Caixa (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Lucro Líquido | -$63.0M | -$73.2M | $99.9M | -$94.7M | -$111.2M | $127.8M | -$280.3M | -$263.5M | -$227.1M | -$193.9M |
| Depreciação e Amortização | $544000 | $2.7M | $4.0M | $7.2M | $8.4M | $9.6M | $12.9M | $17.3M | $16.2M | $15.6M |
| Compensação em Ações | $7.0M | $10.6M | $16.6M | $26.9M | $31.9M | $38.8M | $40.8M | $40.3M | $38.5M | $34.6M |
| Variação Capital de Giro | $5.2M | $897000 | -$7.8M | -$5.3M | $14.2M | $40.2M | $14.0M | -$10.9M | $5.5M | $11.8M |
| Fluxo de Caixa Operacional | -$48.6M | -$58.0M | $104.6M | -$107.7M | -$54.1M | $218.9M | -$207.5M | -$218.4M | -$173.1M | -$124.0M |
| CapEx | -$8.1M | -$7.2M | -$13.3M | -$11.7M | -$26.9M | -$84.2M | -$30.7M | -$10.0M | -$2.4M | -$2.4M |
| Aquisições | 0 | -$479000 | -$179.7M | -$296.0M | -$149.6M | -$5.0M | 0 | 0 | 0 | 0 |
| Recompra de Ações | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.2M | 0 |
| Dividendos Pagos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | -$56.7M | -$65.2M | $91.4M | -$119.4M | -$80.9M | $134.7M | -$238.2M | -$228.4M | -$175.6M | -$126.4M |
Fluxo de Caixa (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Fluxo de Caixa Operacional | -$56.0M | -$52.3M | -$76.2M | -$62.2M |
| CapEx | -$491000 | -$508000 | -$1.2M | -$760000 |
| Fluxo de Caixa Livre | -$56.5M | -$52.8M | -$77.4M | -$63.0M |
| Dividendos Pagos | 0 | 0 | 0 | 0 |
| Compensação em Ações | $9.0M | $8.4M | $8.6M | $9.1M |
Crescimento e Margens (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crescimento Receita (anual) | | +126.5% | +2002.4% | -83.9% | +338.7% | +204.3% | -76.0% | -19.9% | -7.7% | +104.5% |
| Crescimento Lucro Líquido (anual) | | -16.2% | +236.6% | -194.8% | -17.4% | +214.9% | -319.3% | +6.0% | +13.8% | +14.6% |
| Crescimento LPA (anual) | | -2.9% | +211.4% | -194.5% | -15.5% | +201.0% | -315.9% | +7.4% | +23.8% | +18.1% |
| Variação de Ações (anual) | | +13.1% | +22.7% | +0.1% | +1.6% | +17.8% | -1.7% | +1.3% | +13.2% | +4.2% |
| Crescimento FCF (anual) | | -14.9% | +240.2% | -230.7% | +32.2% | +266.4% | -276.8% | +4.1% | +23.1% | +28.0% |
| Margem Bruta | 79.1% | 83.6% | 95.6% | 76.6% | 76.9% | 89.0% | 51.6% | 58.8% | 59.7% | 88.1% |
| Margem Operacional | -1423.8% | -730.2% | 40.3% | -422.9% | -77.1% | 34.0% | -233.2% | -297.1% | -280.0% | -94.6% |
| Margem EBITDA | -1412.0% | -704.3% | 42.1% | -256.4% | -62.6% | 37.7% | -216.7% | -265.4% | -237.9% | -78.2% |
| Margem Líquida | -1372.1% | -704.0% | 45.7% | -268.9% | -72.0% | 27.2% | -248.7% | -292.0% | -272.5% | -113.8% |
| Margem FCF | -1235.7% | -626.9% | 41.8% | -339.0% | -52.4% | 28.6% | -211.3% | -253.1% | -210.7% | -74.1% |
| Taxa Efetiva de Imposto | 0.7% | -0.9% | 4.0% | 2.8% | -4.9% | 9.5% | 0.0% | 0.1% | -0.0% | -0.0% |
Dados por Ação (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Ação | $-2.15 | $-2.18 | $2.49 | $-3.25 | $-2.17 | $3.07 | $-5.52 | $-5.22 | $-3.55 | $-2.45 |
| Dividendo por Ação | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Ações em Circulação (Básicas) | $26.4M | $29.9M | $36.6M | $36.7M | $37.3M | $42.4M | $43.2M | $43.7M | $49.5M | $51.6M |
O que olhar em Biotech
A maioria das biotechs pequenas perde dinheiro. Analisar com P/E não faz sentido — olha caixa e pipeline.
- Cash Runway — Meses de caixa ao ritmo atual de gasto. <18 meses = risco de diluição urgente
- Cash burn anual — Ritmo a que queimam caixa operacional. Comparar com posição de caixa para projetar runway
- Dívida Total — Biotech sem receita + dívida = receita para falência
- I+D / Capitalização — Quanto investem em pipeline vs valor da empresa — indicador de intensidade de pesquisa
- Market cap / Caixa — Se cota perto do caixa, o mercado dá ~0 valor ao pipeline — oportunidade ou armadilha
Rentabilidade
| Retorno sobre patrimônio | -220.07% |
| Retorno sobre capital investido | -52.72% |
| Retorno sobre ativos | -50.81% |
| Margem bruta | 54.22% |
| Margem operacional | -94.08% |
| Margem líquida | -112.58% |
Saúde financeira
| Dívida / Patrimônio | 0.96 |
| Liquidez corrente | 2.86 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -2.57 |
Índices Chave (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/L | -7.79 | -13.57 | 15.37 | -15.88 | -15.22 | 10.86 | -3.49 | -2.98 | -1.68 | -3.83 |
| P/VP | 3.03 | 5.43 | 3.02 | 3.34 | 4.48 | 1.82 | 1.90 | 2.52 | 1.47 | 7.23 |
| P/V | 106.75 | 95.55 | 7.03 | 42.66 | 10.94 | 2.95 | 8.68 | 8.70 | 4.59 | 4.36 |
| Margem Bruta | 79.1% | 83.6% | 95.6% | 76.6% | 76.9% | 89.0% | 51.6% | 58.8% | 59.7% | 88.1% |
| Margem Operacional | -1423.8% | -730.2% | 40.3% | -422.9% | -77.1% | 34.0% | -233.2% | -297.1% | -280.0% | -94.6% |
| Margem Líquida | -1372.1% | -704.0% | 45.7% | -268.9% | -72.0% | 27.2% | -248.7% | -292.0% | -272.5% | -113.8% |